nicardipine hydrochloride · Chiesi · NDA 019734
Cardene In 0.83% Sodium Chloride In Plastic Container
Earliest generic entry, as listed
26 Dec 2027
Blocked by patent: US 7612102, US 9364564.
Listed patents · 6 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7612102 | drug product · sets the listed date | 26 Dec 2027 |
| US 9364564 | drug product · sets the listed date | 26 Dec 2027 |
| US 10758616 | drug product | 18 Apr 2027 |
| US 11547758 | use U-1029 | 18 Apr 2027 |
| US 7659291 | use U-1029 | 18 Apr 2027 |
| US 8455524 | use U-1029 | 18 Apr 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019734 · 004 · RLD | injectable, intravenous | 40MG/200ML (0.2MG/ML) | 26 Dec 2027 |